|
|
|
| Observation on the Curative Effect of Kuntai Capsule Combined with Fenmotong(complex packing estradiol) in the Treatment of Perimenopausal Syndrome |
| FU Li-Xia |
| The Centre of Women's Health, Chengdu Women and Children Centre Hospital, Chengdu, Sichuan,610091 |
|
|
|
|
Abstract 【Objective】To investigate the effect of Kuntai capsule combined with complex packing estradiol(Fenmotong) in the treatment of perimenopausal syndrome.【Methods】A total of 146 perimenopausal patients who were treated in our hospital from October 2016 to October 2017 were randomly divided into control group and observation group. Each group had 73 cases. The control group was given complex packing estradiol cycle sequential treatment. The observation group was given Kuntai Capsule on the basis of the control group. The clinical efficacy, ovarian function, quality of life and adverse drug reactions before and after treatment were compared between the two groups.【Results】There was no significant difference in FSH, AFC, LH, E2, MENQOL and clinical symptom score between the two groups before treatment (P>0.05); after treatment, the improvement effect of FSH, AFC, LH and E2 in the observation group was significantly higher than that in the control group (P<0.05); the clinical symptom score and ENQOL score in the observation group were significantly lower than those in the control group (P<0.05). In the control group (P<0.05), the total effective rate in the observation group was significantly higher than that in the control group (P<0.05); there was no significant difference in the incidence of side effects between the two groups (P>0.05). 【Conclusion】Kuntai capsule combined with Fenmotong in the treatment of perimenopausal syndrome can improve the clinical symptoms and ovarian function of patients, improve the clinical efficacy and quality of life, and is relatively safe, which is worthy of clinical application.
|
|
Received: 27 November 2018
|
|
|
|
|
|
[1] 雷鹏琼,李彦洁.身心疗法对围绝经期症状影响的研究进展[J].中国老年学杂志,2016,36(21):5467-5470.
[2] 陈欣舒,王轶蓉.中医药治疗围绝经期综合征的临床研究进展[J].国际中医中药杂志,2017,39(12):1148-1150.
[3] 陈继明,高红艳,李沁.坤泰胶囊治疗围绝经期综合征患者30例临床观察[J].中医杂志,2015,56(3):231-234.
[4] 曹泽毅.中华妇产科学(第2版)[M].北京:人民卫生出版社,2004:2537.
[5] 冯冬兰,李改非.中医妇产科学[M].长春:吉林大学出版社,2015:38-42.
[6] Tao MF,Shao HF,Li CB,et al.Correlation between the modified Kupperman Index and the Menopause Rating Scale in Chinese women[J].Patient Prefer Adherence,2013,7:223-229.
[7] 张洪涛.临床妇产科学[M].北京:第二军医大学出版社,2011:362-367.
[8] Nie G,Yang H,Liu J,et al.Psychometric properties of the Chinese version of the Menopause-Specific Quality-of-Life questionnaire[J].Menopause,2016,24(5):546-554.
[9] 樊雪琳.坤泰胶囊与戊酸雌二醇治疗围绝经期综合征临床疗效观察[J].中医临床研究,2016,8(9):28-29.
[10] 宋佳怡,夏天,马瑞红,等.和颜坤泰胶囊治疗卵巢储备功能下降的机制探讨及前景分析[J].中国中医药现代远程教育,2016,14(8):145-147.
[11] 徐文君,高慧,李杨,等.坤泰胶囊对卵巢早衰大鼠的治疗作用及其机制研究[J].药物评价研究,2017,40(3):314-318.
[12] 陈继明,高红艳,李沁.坤泰胶囊治疗围绝经期综合征患者30例临床观察[J].中医杂志,2015,56(3):231-234. |
|
|
|
2019, Vol. 36 
